European Medicines Agency

7 data points extracted from 3 publications by this organisation.

Data points
7
Documents
3
Indicators
7
Regions
1
Publisher type
Government

Bibliography

Documents used

Every publication we have taken a number from, with the date we read it and the link status at that time.

Document Type Published Retrieved Link Data points
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026 Licence: See source Press release 15 Sep 2026 Reachable 2
EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines Licence: See source Press release 17 Sep 2026 Reachable 3
Human medicines: highlights of 2022 Licence: See source Press release 17 Sep 2026 Reachable 2

Every figure

Data points

Every figure taken from this organisation, grouped by indicator.

7 data points across 7 indicators.
IndicatorRegionPeriodValueTypeFull record
Generic medicines receiving positive opinion (monthly)European UnionJuly 20263actual
Human medicines recommended for marketing authorizationEuropean Union2025104actual
Human medicines recommended for marketing authorization with new active substanceEuropean Union202538actual
Human rare disease medicines recommended for marketing authorisationEuropean Union202516actual
Medicines recommended for marketing authorisationEuropean Union202289actual
Medicines with new active substances recommended for marketing authorisationEuropean Union202242actual
New medicines recommended for approval (monthly)European UnionJuly 202612actual

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. Credit European Medicines Agency as the original publisher; each record page carries its own citation.

European Medicines Agency. Retrieved from StatOrigin: https://statorigin.org/sources/european-medicines-agency

Keep exploring

Related

Last verified 17 September 2026. Link status is rechecked weekly.